CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 120 enrolled
Drug / intervention
Stannous Fluoride Dentifrice +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06892834
NCT06892834Phase 2Completed

A Three-month Clinical Study to Assess the Gingivitis Effect of Various Dentifrices.

Procter and Gamble·interventional·Posted Mar 25, 2025·Updated May 4, 2026

In Brief

A Phase 2 clinical trial evaluating Stannous Fluoride Dentifrice, Sodium Fluoride Dentifrice, and 1 other intervention for Gingivitis. Completed, enrolled 120 participants across 1 site.

Detailed Summary

The primary objective of this study is to evaluate the effect of two experimental hops extract-containing dentifrices on gingivitis relative to a positive control 0.454% SnF2 dentifrice and a negative control dentifrice after 12 weeks of product use.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGingivitis
CountriesCanada
Collaborators--

Timeline

Phase 2CompletedFinished
2026
First PostedMar 25, 2025
Enrollment StartMar 25, 2025
Primary CompletionJun 19, 2025
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 1.3 years ago

Interventions

Stannous Fluoride Dentifricedrug

Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 12 weeks (\~3 months).

Sodium Fluoride Dentifricedrug

Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 12 weeks (\~3 months).

Sodium monofluorophosphate dentifricedrug

Each subject will be randomly assigned to one of four treatment products and will be asked to brush 2x a day (1 minute per brushing) for 12 weeks (\~3 months).